April 24, 2026 · Form 4 insider transaction
Lubner David Charles sold 53,625 shares of Dyne Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 4 days after the transaction.